These researchers have observed that in 7.8% of BC tumors, the expression of the p85α protein is reduced, which they associated with the overactivation of the PI3K/AKT pathway due to the loss of the inhibitory effect of p85α on p110α. Here, AKT1 is linked to breast cancer.